Namodenoson in Advanced Hepatocellular Carcinoma and Child-Pugh B Cirrhosis: Randomized Placebo-Controlled Clinical Trial.

MLA

Stemmer, Salomon M., et al. “Namodenoson in Advanced Hepatocellular Carcinoma and Child-Pugh B Cirrhosis: Randomized Placebo-Controlled Clinical Trial.” Cancers, vol. 13, no. 2, Jan. 2021. EBSCOhost, https://doi.org/10.3390/cancers13020187.

APA

Stemmer, S. M., Manojlovic, N. S., Marinca, M. V., Petrov, P., Cherciu, N., Ganea, D., Ciuleanu, T. E., Pusca, I. A., Beg, M. S., Purcell, W. T., Croitoru, A.-E., Ilieva, R. N., Natošević, S., Nita, A. L., Kalev, D. N., Harpaz, Z., Farbstein, M., Silverman, M. H., Bristol, D., … Fishman, P. (2021). Namodenoson in Advanced Hepatocellular Carcinoma and Child-Pugh B Cirrhosis: Randomized Placebo-Controlled Clinical Trial. Cancers, 13(2). https://doi.org/10.3390/cancers13020187

Chicago

Stemmer, Salomon M, Nebojsa S Manojlovic, Mihai Vasile Marinca, Petar Petrov, Nelly Cherciu, Doina Ganea, Tudor Eliade Ciuleanu, et al. 2021. “Namodenoson in Advanced Hepatocellular Carcinoma and Child-Pugh B Cirrhosis: Randomized Placebo-Controlled Clinical Trial.” Cancers 13 (2). doi:10.3390/cancers13020187.